Related Experiment Video
Updated: Dec 9, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
miRNA-182 regulated MTSS1 inhibits proliferation and invasion in Glioma Cells
Zhexuan Li1, Longbo Zhang1, Zhiqiang Liu1
1Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Abstract:
Human glioma is the most common malignant and fatal primary tumor in the central nervous system. Currently, the high incidence and low cure rate of glioma make it a considerable threat to human health. Thus, elucidating the molecular mechanisms of glioma development and progression has become a major focus to identify new and effective biomarkers and improve the comprehensive neurosurgical treatment of glioma from the basic research and clinical perspectives. In our present study, we aimed to investigate the expression pattern and biological function of Metastasis suppressor protein 1(MTSS1) in glioma and to further explore whether miRNAs were involved in the deregulation of MTSS1. By overexpressing MTSS1 in highly malignant human glioma cells, we discovered a role for MTSS1 in suppressing the proliferation and invasion of glioma cells, and we showed that MTSS1 participated in transforming growth factor-beta 1 (TGF-β1) -induced epithelial-mesenchymal transition (EMT) in glioma cells. Biochemical analyses suggested that miR-182 may target MTSS1 and that miR-182 expression is negatively correlated with MTSS1 expression in glioma tissues. This finding was further confirmed by luciferase reporter experiments. Furthermore, a miR-182 inhibitor induced glioma cell proliferation and invasion by increasing MTSS1 expression. In conclusion, we believed that miR-182 modulates glioma cell migration and invasion by targeting the MTSS1 and suggested that miR-182 was a potential therapeutic target for gliomas.
Insights
Metastasis suppressor protein 1 (MTSS1) inhibits glioma cell proliferation and invasion. MicroRNA-182 (miR-182) targets MTSS1, suggesting miR-182 as a potential therapeutic target for glioma treatment.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Glioma, a common and fatal brain tumor, necessitates understanding its molecular mechanisms for improved treatment.
- Identifying novel biomarkers and therapeutic targets is crucial for advancing glioma care.
Purpose of the Study:
- To investigate the role of Metastasis suppressor protein 1 (MTSS1) in human glioma.
- To explore the involvement of microRNAs (miRNAs) in regulating MTSS1 expression in glioma.
- To assess the therapeutic potential of targeting the miR-182/MTSS1 axis in glioma.
Main Methods:
- Overexpression of MTSS1 in human glioma cells to assess its biological function.
- Analysis of MTSS1's role in transforming growth factor-beta 1 (TGF-β1)-induced epithelial-mesenchymal transition (EMT).
- Luciferase reporter assays to confirm the targeting relationship between miR-182 and MTSS1.
- Correlation analysis of miR-182 and MTSS1 expression in glioma tissues.
- Inhibition of miR-182 to evaluate its effect on glioma cell proliferation and invasion.
Main Results:
- MTSS1 overexpression suppressed glioma cell proliferation and invasion.
- MTSS1 was found to participate in TGF-β1-induced EMT in glioma cells.
- miR-182 was identified as a direct target of MTSS1, with inverse correlation in glioma tissues.
- Inhibition of miR-182 led to increased glioma cell proliferation and invasion.
Conclusions:
- miR-182 modulates glioma cell migration and invasion by targeting MTSS1.
- The miR-182/MTSS1 pathway represents a potential therapeutic target for glioma.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

